​

Aligos Therapeutics (ALGS) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Aligos Therapeutics Revenue Highlights

0

Latest Revenue (Q)

$311.00K

Aligos Therapeutics Revenue by Period

Aligos Therapeutics Revenue by Year

DateRevenueChange
2024-12-31--100.00%
2023-12-31$15.53M11.66%
2022-12-31$13.91M219.04%
2021-12-31$4.36M100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31--

Aligos Therapeutics generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Aligos Therapeutics Revenue by Quarter

DateRevenueChange
2025-03-31$311.00K-50.56%
2024-12-31$629.00K-50.43%
2024-09-30$1.27M19.60%
2024-06-30$1.06M7.61%
2024-03-31$986.00K-63.22%
2023-12-31$2.68M-17.23%
2023-09-30$3.24M-52.96%
2023-06-30$6.89M152.88%
2023-03-31$2.72M-23.01%
2022-12-31$3.54M-13.86%
2022-09-30$4.11M11.18%
2022-06-30$3.69M43.64%
2022-03-31$2.57M600.54%
2021-12-31$367.00K-76.12%
2021-09-30$1.54M-0.52%
2021-06-30$1.54M69.78%
2021-03-31$910.00K100.00%
2020-12-31--100.00%
2020-09-30$2.03M100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-06-30-100.00%
2018-03-31--

Aligos Therapeutics generated $311.00K in revenue during Q1 2025, up -50.56% compared to the previous quarter, and up 11.60% compared to the same period a year ago.

Aligos Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
MRSNMersana Therapeutics$40.50M$3.06M
CELUCelularity$22.77M$18.13M
VERUVeru$16.89M-
BRNSBarinthus Biotherapeutics$14.97M-
CUECue Biopharma$5.49M$2.95M
INMBINmune Bio$14.00K$50.00K
ALGSAligos Therapeutics-$311.00K
RLMDRelmada Therapeutics--
NRXPNRx Pharmaceuticals--
TPSTTempest Therapeutics--
ACRVAcrivon Therapeutics--

ALGS Revenue FAQ

What is Aligos Therapeutics’s yearly revenue?

Aligos Therapeutics's yearly revenue for 2024 was $0, representing a decrease of -100.00% compared to 2023. The company's yearly revenue for 2023 was $15.53M, representing an increase of 11.66% compared to 2022. ALGS's yearly revenue for 2022 was $13.91M, representing an increase of 219.04% compared to 2021.

What is Aligos Therapeutics’s quarterly revenue?

Aligos Therapeutics's quarterly revenue for Q1 2025 was $311K, a -50.56% decrease from the previous quarter (Q4 2024), and a -68.46% decrease year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $629K, a -50.43% decrease from the previous quarter (Q3 2024), and a -76.54% decrease year-over-year (Q4 2023). ALGS's quarterly revenue for Q3 2024 was $1.27M, a 19.60% increase from the previous quarter (Q2 2024), and a -60.82% decrease year-over-year (Q3 2023).

What is Aligos Therapeutics’s revenue growth rate?

Aligos Therapeutics's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was 0%.